External Contributor
These are all the posts from our lovely external contributors. If you want to contribute too, drop us a line at contact-at-labiotech.eu
Antibodies: A Beacon of Hope During the Covid-19 Pandemic Dark Days?
The Complications Around Patenting Biotechnology
The Funding Flow Between European and US Life Sciences
PREP-ing for Future Pandemics and AMR
Negotiating Early-Stage Biotech Valuation: VC vs Entrepreneur
Overcoming the Limitations of CRISPR Gene Editing with RNA Editing
Meet 10 European Biotech Initiatives Increasing Wildlife Biodiversity
UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck
AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal
Bavarian Nordic’s Vaccine Shows Biodefense Potential in Phase I
